Buscar

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Leer más About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. Acerca de Helix Helix es la compañía líder en genómica y vigilancia viral de la población cuyas operaciones se basan en el cuidado clínico, la investigación y el análisis de datos. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Leer más About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Kerry Kelly, MPH has joined Renown Health as Community Health Program Manager. Ms. Kelly comes to Renown from the Food Bank of Northern Nevada where she served as Director of Programs and Community Engagement. She had previously been employed as a Medical Practice Supervisor with Renown Children’s, responsible for managing the day-to-day operations of three ambulatory pediatrics medical practices. With her extensive background in public health and community engagement, Kerry brings a wealth of experience to the role of Community Health Program Manager. Ms. Kelly will play a pivotal role in fostering Community Benefit health initiatives that address northern Nevada’s most pressing health needs, reduce health disparities, promote community wellness, and improve access to care for vulnerable populations. “We are excited to welcome Kerry as our new Community Health Program Manager,” said Suzanne Bharati Hendery, MA, APR, Chief Communications & Customer Officer. “Community is at the center of our mission, and we embrace our commitment to make a genuine difference in creating a healthier Nevada for all. Kerry has a passion for community health and a proven track record in driving initiatives that promote health equity, increase insurance coverage, and enhance health outcomes. The vital role that Renown Health plays as the only local, not-for-profit, charitable healthcare network in Reno will be strengthened by her commitment. We look forward to the innovative strategies and partnerships she will bring to further enhance the health of the community we serve.” Kerry completed her Master’s of Public Health with an emphasis in Community Health Education at San José State University and her BA in Psychology, Community Health Science at the University of Nevada, Reno. Kerry will report directly to Sierra Kelly Martinez, MPH, Director of the Customer Engagement Center. Renown Health has long-standing commitment to the community than spans more than 160 years. This commitment has grown and evolved through significant thought and care in considering our community’s most pressing health needs. One way this is done is through conducting a periodic, comprehensive Community Health Needs Assessment (CHNA). Through the CHNA process, Renown Health identifies the greatest health needs, and ensures resources are appropriately directed toward outreach, prevention, education, and wellness opportunities where the greatest impact can be realized. For more information on the most current Community Health Needs Assessment, visit renown.org/About/Community-Commitment/Community-Health-Needs-Assessment. Renown Health also funds and supports NevadaTomorrow.org, a website that can be accessed free of charge, and provides residents with up-to-date sources of quality-of-life data (such as health and socio-economic information), key reports that describe our community’s current quality of life needs, promising practices to improve people’s overall quality of life, and quality of life improvement efforts in our community. Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health

Leer más About Kerry Kelly, MPH Selected as Community Health Program Manager for Renown

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. En virtud de los términos del acuerdo de colaboración y licencia, Gilead proporcionará fondos al Renown IHI para secuenciar y analizar el ADN de 15,000 personas que viven con EHNA o con enfermedad de hígado graso no alcohólico (EHGNA), así como de una cohorte de control de 40,000 personas en el estado de Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health es la red de atención médica más completa e integrada de Nevada y mantiene registros médicos electrónicos para 1.02 millones de pacientes registrados. En 2016, Renown Health y el Desert Research Institute crearon el Healthy Nevada Project (HNP), el primer estudio de salud poblacional basado en la comunidad del país. En 2017, el HNP comenzó una sociedad con Helix para aprovechar sus servicios de salud poblacional, la secuenciación Exome+™ y las herramientas de participación del consumidor. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. El HNP actualmente tiene 40,000 participantes. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. La EHNA es más frecuente en personas con ciertas afecciones, que incluyen obesidad y diabetes tipo 2. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead opera en más de 35 países alrededor del mundo, con sede central en Foster City, California. Para obtener más información sobre Gilead Sciences, visite el sitio web de la empresa en www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Mediante el uso de su ensayo Exome+™ de propiedad exclusiva, un exoma de tipo panel mejorado con más de 300,000 regiones no codificantes informativas, Helix ofrece a los sistemas de salud una solución escalable que permite el descubrimiento de información genética médicamente relevante y que potencialmente puede salvar vidas. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Obtenga más información en www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. Estos y otros riesgos se describen en detalle en el Informe Trimestral de Gilead en el Formulario 10-Q para el trimestre que finalizó el 31 de marzo de 2019, presentado ante la Comisión de Bolsa y Valores de los EE. UU. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Leer más About Gilead Sciences y el Renown Institute for Health Innovation anuncian una colaboración estratégica para promover la comprensión de la esteatohepatitis no alcohólica (EHNA)

The study could expand to a quarter million people, making Nevada the only state in the U.S. to offer such a program. Las Vegas, Nev. (2 de mayo de 2019) – El Healthy Nevada Project, un estudio de salud poblacional basado en la comunidad primero en su clase que combina datos genéticos, clínicos, ambientales y sociales, está ampliando la inscripción a Las Vegas. The Project aspires not only to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile but ultimately, to develop and expand the Project for communities across the United States to drive positive health outcomes nationwide.   Se agregarán 25,000 voluntarios del estudio en el sur de Nevada El Healthy Nevada Project anuncia extensión a nivel estatal: abre 25,000 vacantes para pruebas en Las Vegas. Ahora que el sur de Nevada abre sus puertas al estudio, el Healthy Nevada Project ofrecerá pruebas genéticas sin costo mediante una muestra de saliva simple a 25,000 voluntarios del estudio. Study volunteers will take Helix’s clinical-grade DNA saliva test and will receive their ancestry and traits, at no cost, through the My Healthy Nevada Traits app. Participants will then be given a chance to answer a follow-up health survey from Renown Institute for Health Innovation (Renown IHI), and upon survey completion, will be entered to win an iPhone. In addition, study participants can agree to be notified about genetic test results that could impact their health, and which could be used to improve their medical care. This return of clinical results, plus genetic counseling and other genetic services as appropriate, will be provided by Genome Medical, the leading network of clinical genetics specialists.   Evolución y expansión continua del Healthy Nevada Project Con más de 35,000 participantes del estudio inscritos en apenas más de dos años, el Healthy Nevada Project se ha convertido en el estudio genético de más rápida inscripción del país. The Project was created by Renown IHI – a collaboration between Reno, Nev.-based not-for-profit health network, Renown Health, and the world leader in environmental data, Desert Research Institute (DRI). Leveraging Renown’s forward-thinking approach to community health care and DRI’s data analytics and environmental expertise, Renown IHI has grown its capabilities to lead a larger, more complex research study of significance that will analyze and model public health risks in Nevada and serve as a national model for future population health studies working to improve overall health through clinical care integration. En el lanzamiento piloto del proyecto el 2016 de septiembre, se inscribieron más de 10,000 miembros de la comunidad para realizarse pruebas de ADN en solo 48 horas. En marzo de 2018, en la fase dos, se les ofreció a los residentes del norte de Nevada secuenciación genómica completa mediante una simple prueba de saliva de Helix. En octubre de 2018, el proyecto anunció la devolución de los resultados clínicos a los participantes del estudio. Allí se notificaba el riesgo que tenían de padecer afecciones de Nivel 1 de los CDC, que incluyen hipercolesterolemia familiar, BRCA1 y BRCA2 positivo, y síndrome de Lynch, un precursor del cáncer de colon. These conditions affect more than one percent of the population and are inherited so they impact family members as well. Ahora, el proyecto anunció su próxima fase: la extensión de la inscripción a 25,000 personas del sur de Nevada.   Serving as a National Model This expansion to Las Vegas truly makes this the “Healthy Nevada Project” with a statewide impact making Nevada the only state in the U.S. to offer such a program. “Nevada was ripe to advance population health goals because, sadly, our state ranks near the bottom in health outcomes. The Healthy Nevada Project is working to change that,” said Anthony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health and president of Renown IHI. “Nuestros investigadores están trabajando en una serie de programas clínicos y estudios científicos para determinar por qué en el condado de Washoe, el condado en el que se encuentra Renown Health, las tasas de mortalidad etarias para enfermedad cardíaca, cáncer y enfermedad crónica de las vías respiratorias inferiores de Nevada son un 33 por ciento más altas que la tasa nacional. Imagine if we can gather more data like this on a national scale and use it to change the future of health and health care? That is what the Healthy USA Project is looking to do in the years to come.” “The Healthy Nevada Project is committed to providing study participants clinically actionable data that will help improve their health,” said Joseph Grzymski, Ph.D., associate research professor at DRI, principal investigator of the Healthy Nevada Project and chief scientific officer for Renown Health. “We are providing this information at the individual level so study volunteers can make lifesaving changes to reduce their risk. We’re also doing it on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country.”   Expanding to Become the Healthy USA Project The accelerated speed of the Project is made possible thanks to the ever-decreasing cost of sequencing. Hoy en día, Helix puede secuenciar un exoma completo, lo que permite informar sobre la mayoría de los conocimientos genómicos prácticos, por una fracción de lo que habría costado hace solo 10 años. Additionally, advances in digital health mean Helix and Project researchers can capture unprecedented amounts of health data digitally, making significant contributions to advancing precision health. The partnership has managed to remove the traditional barriers of population health studies, including the difficulty in recruiting participants, establishing quality high through put lab systems, and scaling interpretation and return of results. This development will be key as other health systems around the country join the Project. “We are thrilled to see the constant, fast-paced evolution of this Project with Renown IHI,” said Justin Kao, CoFounder of Helix. “In less than a year, we have sequenced the DNA of thousands of study participants and are now preparing to offer this incredible study in other states. Combining environmental, clinical, social and genetic data allows us to discover risk factors within communities and help people take action to live longer, healthier lives. That’s what makes the next step of the Healthy USA Project so exciting for all of us. “Los detalles completos sobre la evolución del estudio y de la inscripción en el sur de Nevada se darán a conocer en un evento de prensa en Las Vegas el martes 7 de mayo a las 3 p.m. Renown Institute for Health Innovation es una colaboración entre Renown Health, una red de atención médica integrada de administración y propiedad local y sin fines de lucro que brinda servicios a Nevada, Lake Tahoe y el noreste de California, y el Desert Research Institute, líder mundial reconocido en la investigación de los efectos del cambio ambiental natural e inducido por el humano y en la promoción de tecnologías para la evaluación de un planeta cambiante. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Obtenga más información en https://healthynv.org/.  Helix es una empresa de genómica con una misión simple pero potente: to empower every person to improve their life through DNA. Our affordable, turnkey population health solution enables institutions to quickly scale projects that engage communities and accelerate research and discovery, ultimately allowing every person to benefit from the power of genomics. We've also created the first marketplace for DNA-powered products where people can explore diverse and uniquely personalized products developed by high-quality partners, providing powerful tools to increase engagement and speed the pace of population-scale genomics. Helix is headquartered in the San Francisco Bay Area, has an office in Denver, Colorado and operates a CLIA-certified and CAP-accredited next-generation sequencing lab in San Diego powered by Illumina (NASDAQ: ILMN) NGS technology. Helix fue creada en 2015. Obtenga más información en www.helix.com. Helix, el logotipo de Helix y Exome+ son marcas comerciales de Helix Opco, LLC. All other trademarks referenced herein are the property of their respective owners.   Additional Media Contacts: Tracy Bower                                                                                                                                                                          DRI                                                                                                                                                                                      702-862-5404                                                                                                                                                      media@dri.edu Eric Schubert                                                                                                                                                                        Seismic for Helix                                                                                                                                                                    415-939-4366                                                                                                                                                    press@helix.com

Leer más About Estudio de salud poblacional se extiende a todo el estado y abre la inscripción

Presented by the Desert Research Institute and Renown Health, DANA will help people learn more about the Healthy Nevada Project® and their own unique, genetic health traits What is the Healthy Nevada Project®? What are the benefits of joining this research study? How can I find out if I carry genes for health risks like heart disease, hereditary breast and ovarian cancer syndrome and Lynch syndrome? What if a holographic avatar, powered by artificial intelligence (AI), could answer all these questions and more? DANA has all the answers, she is a virtual assistant with “DNA” in her name, presented by the Renown Institute for Health Innovation (Renown IHI), a collaboration between Renown Health and the Desert Research Institute (DRI). This life-sized, holographic avatar will greet individuals outside Renown Regional Medical Center’s Sierra Café, and talk to them about the Healthy Nevada Project, the world’s largest community-based genetic population health study. Los representantes de medios de comunicación están invitados a reunirse con DANA esta mañana, desde las 10 a.m. hasta el mediodía. Responda a este correo electrónico o llame al (775) 691-7308 para coordinar una reunión. “Unfortunately, Nevada ranks among the lowest in the nation for health outcomes—and we are working to change that,” said Anthony Slonim, M.D., D.Ph., president and CEO of Renown Health and president of Renown Institute for Health Innovation. “Through the Healthy Nevada Project® , our goal is to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile. Thanks to this advanced technology, DANA will offer people a personalized explanation of the Project, and help them take the next step to better understand their health, and their health risks, so they can modify their behavior and ultimately, live a healthier, happier life.” Con más de 51,000 participantes del estudio inscritos hasta la fecha, el Healthy Nevada Project® se considera el estudio genético de más rápida inscripción del país. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. Furthermore, participants can choose to share their information with their medical provider to improve and enhance their medical care. “We are always happy to engage with our study participants and look forward to having them meet and engage with DANA,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “At a time of physical distancing and limiting human contact where possible, using tools like an avatar and AI are important for communicating, whether it be for genetics, vaccinations or other important health information.” Visitors can interact with DANA through a touch screen (cleaned and sanitized after every encounter) to learn more about the study, enter their contact information and schedule an appointment to join the free genetics study or receive more information about their test results. Kiosk visitors are asked to maintain physical distance guidelines and use the hand sanitizer and Sani Wipes available next to the kiosk.     Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Leer más About Presentación de Dana, el nuevo quiosco holográfico tamaño real del Renown Institute for Health Innovations

El enfoque basado en la comunidad del Healthy Nevada Project revela que hasta un 90 % de los riesgos de padecer afecciones genéticas de Nivel 1 de los CDC no se detecta cuando se usan pautas de atención clínica. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. En 2018, el Healthy Nevada Project® (el mayor estudio de salud poblacional basado en la comunidad que combina datos genéticos, clínicos, ambientales y sociales) comenzó a notificarles a los participantes del estudio que habían dado su consentimiento sobre ciertas variantes genéticas que los predisponían a padecer las afecciones genéticas de Nivel 1 de los Centros para el Control y la Prevención de Enfermedades (Centers for Disease Control and Prevention, CDC). The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Los resultados iniciales de casi 27,000 participantes del estudio mostraron que el 90 % de los portadores de las afecciones genéticas de Nivel 1 de los CDC no había sido previamente identificado en un entorno clínico. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Del grupo de 26,906 participantes del Healthy Nevada Project® que el equipo de investigación de Grzymski estudió, 358 (el 1.33 %) eran portadores de afecciones de Nivel 1 de los CDC. Sin embargo, solo el 25 % de esas personas cumplían las pautas clínicas para realizarse exámenes de detección genética. Además, más del 20 % de los portadores ya tenía un diagnóstico de enfermedad relacionada con la afección genética subyacente. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” En particular, el estudio descubrió que de los 273 participantes que eran portadores de las afecciones genéticas de Nivel 1 de los CDC y que tenían información de registros clínicos, solo 22 personas mostraron sospechas previas de tener estas afecciones genéticas subyacentes. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. El Healthy Nevada Project®, que se lanzó en 2016, ofrece pruebas genéticas gratuitas a todos los residentes de Nevada, mayores de 18 años, interesados en obtener más información sobre su salud y perfil genético. Con más de 50,000 participantes del estudio inscritos en cuatro años, el Healthy Nevada Project® se ha convertido en el estudio genético de más rápida inscripción del mundo. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Obtenga más información en www.helix.com.

Leer más About Los exámenes de detección genética poblacionales demuestran que identifican de manera eficiente un aumento en el riesgo de padecer enfermedades hereditarias

Students ages 16 and older can now submit applications for entry-level, non-clinical opportunities at region’s top employer and one of the nation’s Top Places to Work ® Obtaining a career in healthcare has been the goal of many who seek to make a positive difference in the lives of others and improve the health of their communities. Overall employment in healthcare occupations is projected to grow 13 percent from 2021 to 2031, much faster than the average for all occupations; and this increase is expected to result in about 2 million new jobs over the decade, according to the Bureau of Labor Statistics. Today, Renown Health leaders announced they are accepting employment applications for individuals 16 years old to work in entry-level, non-clinical roles; formerly teens needed to be 18 years or older to apply for employment at Nevada’s largest not-for-profit health network. “Many of us who work today as physicians, nurses and key members of the healthcare team, started out as teenagers working or volunteering in our local hospitals,” says Brian Erling, MD, MBA, President & CEO, Renown Health. “Supporting local teens with their first jobs in healthcare, and providing support for life-long careers, helps build the workforce of the future. We are excited to welcome the next generation of Renown employees as they partner with us to care for our community and Fight the Good Fight.” “For more than 160 years, the foundation of our success has been to hire the brightest and most compassionate people,” says Brittany Brown, MBA, Director of Recruitment. High school students curious about a career in healthcare are encouraged to apply to one of the many entry-level, non-clinical positions available now at Renown Health. All entry-level positions offer flexible schedules to account for school schedules. Named Ragan’s “Top Places to Work for 2022,” Renown Health fosters a caring culture of values that include caring, integrity, collaboration and excellence. Renown was awarded for championing their workforce and providing guidance, initiatives and resources that promote a diverse, equitable and inclusive workplace, offering ample room for professional growth and providing effective communication that keeps employees engaged and informed. “Renown Health is rising to the occasion by expanding employment opportunities for high school students,” said Ms. Brown. “We hope to help teens develop career skills that will serve them today, and for a successful future.” The decision to lower Renown’s minimum employment age to 16 was rooted in the health system’s desire to support students in their long-term career goals and foster their interest in healthcare. Renown’s expert recruiters are poised to welcome teen applicants and be a resource for them throughout the hiring process. Along with offering education and career growth opportunities, Renown has extensive employee benefits available to full time and part time employees. Open part-time and per diem positions available for students who meet the new minimum age requirement of include, but are not limited to: Patient Access Representatives Patient Safety Assistants Patient Transporters Dishwashers Food Service Workers Housekeepers Renown Health also recognizes the value of experienced workers and believes in equal opportunities for all. Part-time, full-time and flexible positions are also available for people 55+ and retirees. Individuals may apply directly at renown.org/careers. Renown Health ensures equal employment opportunity without discrimination or harassment on the basis of race, color, religion, sex, sexual orientation, gender identity or expression, age, disability, marital status, citizenship, national origin, genetic information, or any other characteristic protected by law. For more information, see our non-discrimination policy at renown.org. About Renown Health Renown Health is the region’s largest not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®.

Leer más About Renown Health Lowers Minimum Employment Age To 16 Years Old

Samuel Austin Lee, M.D., Ph.D., FIDSA has joined the University of Nevada, Reno School of Medicine (UNR Med) and Renown Health as Department Chair of Internal Medicine. Dr. Lee comes to Nevada from New England, where he served as Chief of Medicine for the White River Junction (VT) Veteran’s Administration Medical Center and Professor of Medicine at the Geisel School of Medicine at Dartmouth.  Dr. Lee previously served as an Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Texas Health Science Center at San Antonio, and a member of the San Antonio Center for Medical Mycology.  He next served on the faculty for University of New Mexico, as Section Chief, Infectious Diseases at the VA Albuquerque Medical Center, and as Medical Director of the HIV clinic at the VA Albuquerque.  Dr. Lee will serve as the joint academic and administrative leader defining clinical operations to expand care; enhancing teaching and training programs vital to ambulatory and acute care medicine in northern Nevada, and fostering clinical and translational research and diversity missions. Dr. Lee will also serve as the liaison to the VA Sierra Nevada Health Care System, expanding the 30-year academic partnership to enhance general internal medicine and specialty services critical to the community. “We are delighted to have Dr. Lee join us,” said Paul J. Hauptman, MD, Dean of UNR Med and Chief Academic Officer for Renown Health. “He has a strong background in academic medicine, demonstrated excellence in clinical care, medical education and research, and is universally respected as a compassionate physician leader. Dr. Lee will do much to advance the mission of UNR Medicine’s Internal Medicine Residency program and expand related Graduate Medical Education opportunities, thereby helping to train the next generation of physicians.”  “Dr. Lee is a collaborative physician, researcher and mentor who cares deeply about improving the health of our community,” said Brian Erling, MD, MBA, President and CEO, Renown Health. “This is an exceptionally exciting time for him to help craft our vision to offer more efficient and affordable care, elevate the patient experience, and advance health equity across northern Nevada. He will further elevate our mission of outstanding care, exceptional training, innovative research, impactful advocacy, and innovative community partnerships. We are fortunate to have him joining our team and community.” Dr. Lee will oversee the Division Chiefs of Acute Hospital Services at Renown Regional Medical Center, numerous subspecialists across Renown Medical Group, and the Healthy Nevada Project®. He will serve as an active internist and infectious disease subspecialist.  Dr. Lee is a graduate of the seven-year Combined BA/MD Program at Boston University. He completed his internship and residency at the Hospital of the University of Pennsylvania. He then trained in a three-year research track fellowship in Infectious Diseases at Yale University School of Medicine and continued at Yale as a Staff Physician at the VA Connecticut Healthcare System. He obtained his Ph.D. in Investigative Medicine in Yale University’s Graduate School. Dr. Lee’s research explores fungal pathogenesis, secretion, virulence, biofilm formation and antifungal drug discovery. His laboratory work, which has been supported by the National Institute of Allergy and Infectious Diseases (NIAID) and Department of Veterans Affairs Merit awards, involves research on fungal pathogenesis, novel antifungal therapies and treatment approaches against biofilm formation in Candida species, including drug repurposing, high-throughput screening of small molecule compound libraries, and studies of antifungal lock therapies for prevention of catheter-associated infections.  Dr. Lee is recognized for his passion for high-quality patient care and supports future practitioners through rigorous and culturally informed undergraduate and graduate medical education, research, and community collaboration. He maintains active involvement in national committees and editorial boards including Frontiers in Cellular and Infection Microbiology, Plos ONE, Mycopathologia, Virulence, and The Journal of Mycology and is a member of the Peer Review Board for the Journal of Visualized Experiments. Dr. Lee was awarded the New Mexico School of Medicine Regents’ Lecturer Award in recognition of his contributions to clinical medicine, research and education. In 2020, he received special recognition from the Department of Veterans Affairs for his team’s response to the COVID-19 pandemic. About the University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Desde 1969, UNR Med ha capacitado a más de 3,900 estudiantes, residentes y becarios. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Visite renown.org para obtener más información.

Leer más About Samuel Austin Lee, M.D., Ph.D., Appointed Chair of Internal Medicine

Nevada’s #1 ranked hospital system announces plan to hire 500 more physicians, nurses, clinicians for region In recognition of Valentine’s Day, Renown Health today announced a national physician, nurse, and clinical specialist recruitment campaign to help fill positions and expand access to community-based primary and specialty care across northern Nevada.   Over the last year, consumer demand for Renown physicians, providers and services has increased significantly. At the same time, the nationwide physician and nursing shortage that experts predicted has arrived. As a result, in an innovative partnership with over 7,000 employees, the health care system has launched a national recruitment campaign to ensure staffing to meet the needs of a growing patient base and community.     The new recruitment campaign, Fight for You, uses the tag line “Every day, we fight like you. Every day, we fight for you,” to appeal to clinicians and employees devoted to the not-for-profit healthcare system’s mission; to make a genuine difference in the health and well-being of the people and communities.” Watch the video here.    “We honor and celebrate every one of our 7250 employees,” said Brian Erling, MD, MBA, President & CEO of Renown Health, “and have launched this campaign to recruit 500 more dedicated and committed clinicians to care for our patients. Our transformation as a health system demands that we invest in our employees to meet the current healthcare needs of our community. Fight for You is a vibrant campaign that will attract those drawn to Renown’s mission of caring for one and all.”    The campaign is supported by social media promotion on Google, LinkedIn, Facebook, and Instagram. Compelling videos are being promoted on the health system’s website, social media accounts, and used at recruitment events to showcase the diverse faces of the Renown team. All open positions are listed on Renown.org/careers.  In terms of retaining current employees, Renown Health announced that starting 1ro de abril de 2023, they are expanding the 401(k)-retirement plan match based for Renown employees based on an employee’s seniority date. Under this expanded benefit, Renown will continue to invest 4% for employees who participate and have up to 4 years of benefit eligible service. And, for those employees with 5 to 9 years of service, Renown will match your contributions at 5% of your pay, 6% for those at 10-14 years, 7% for 15-19 years - and so on, up to 9% for those who have been at Renown for 25 years or more.    In addition, to support all employees in furthering their education, Renown is increasing educational reimbursement for full and part time employees to the IRS tax free maximum of $5250 and expanding the benefit to per diem employees in the amount of $2625. Per diem employees must meet the per diem requirements to be eligible for reimbursement.      “I am proud of the thousands of physicians, nurses and caregivers who provide exemplary, compassionate care, every day, to Nevadans in need,” said Melodie Osborn, RN, Chief Nurse Executive, Renown Health. “This campaign is about connecting people with a passion for healing and Renown’s mission, vision, and values of caring for the people who live here. Northern Nevada and Lake Tahoe are among the most beautiful places to live and work. We hope our campaign encourages others to consider growing and working for the #1 rated hospital in Nevada.”   As the region’s only Level 2 Trauma Center, Renown serves over 1 million people and 100,000 square miles. Nevada is one of the fastest growing states in the US and the population of Washoe County grew by over 50,000 people between 2010 and 2019, to a population of 471,519.  In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada for 2021. No other hospital in Nevada earned recognition from U.S. News.  About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team visit www.renown.org/careers.

Leer más About More Doctors and Nurses to Serve You! Renown Shares the Love, Investing in Care for Community

Dr. Marie McCormack of Renown Medical Group and Dr. Daniel Spogen of University Health selected as Best in the Nation with 2023 “Excellence in Healthcare” Award from Professional Research Consultants “One of the best I have ever seen.” “Prepared, thorough and tuned in to whole picture.” “Compassionate and listens.” “Wonderful.” “Excellent physician.” Always willing to congratulate successes, answer questions fully and in a way that I can understand and give good advice.” “Exceptional!” “You are knowledgeable, thorough, intelligent and compassionate.” “I love you. Le agradezco”. These are some of the comments made by patients regarding two Reno physicians lauded by Professional Research Consultants, a national firm that interviews patients following their physician and healthcare visits.  The Excellence in Healthcare annual award honors physicians who demonstrate exceptional communications skills in their clinical practice, as awarded by their patients. Recipients of this award are ranked as Top Performers in the “Overall Doctor Rating” and rank in the 100th percentile nationally. Over 3 million patients responded to the Centers for Medicare & Medicaid Services’ (CG-CAPHS) or Clinician and Group Consumer Assessment of Healthcare Providers and Systems patient experience survey in 2022. “We at Renown Health are so proud of Dr. Marie McCormack of Renown Medical Group and Dr. Daniel Spogen of University Health. As Excellence in Healthcare awardees, every one of their patients surveyed in 2022 gave them an A+. These physicians set the gold standard for excellent communications with patients, scoring in the top 1% nationally,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “We are honored that over 500 physicians and advanced practice providers of Renown Medical Group and University Health care for more than 200,000 patients annually at medical practices across Reno, Sparks, Carson City and in our rural communities of Fallon, Fernley, and Silver Springs. In 2022, 17,600 Renown Medical Group patients were surveyed by PRC; 83% of them ranked Renown Medical Group providers as a 9 or 10, the highest rating possible, for physician communication with patients, a key indicator of overall patient satisfaction.” Marie McCormack, MD is a board-certified family physician with an emphasis on preventive health care. She has cared for thousands of patients, from the smallest of babies to golden agers in northern Nevada for 15 years. Dr. McCormack graduated from the University of Nevada, Reno School of Medicine and completed her residency at the University of Kansas.  She currently serves as Medical Director of the Primary Care Group for Renown Medical Group, overseeing primary care for 18 medical offices and more than 70 primary care providers for the largest not-for-profit healthcare network in Northern Nevada. She previously served as the Medical Director for the Rural Clinics seeing patients in Fernley, Fallon, Silver Springs, and Carson City. Dr. McCormack has garnered the highest 5-star rating from over 1,359 actual patients and their comments can be read on the Renown “Find a Provider” website. See video of Dr. McCormack discussing her passion for patient care.   Daniel Spogen, MD is also a board-certified family physician. He has a special interest and emphasis in sports medicine and has served thousands of patients and athletes over his 21 year career with University Health, assisting them with care, treatment, rehabilitation and training so they can return to their sport. Dr. Spogen also served as former Chair, Department of Family Medicine at University of Nevada School of Medicine for over 16 years. He completed his Doctor of Medicine degree from the University of Southern California and his residency at Glendale Adventist Medical Center in CA. More information about Dr. Spogen can be found at https://www.renown.org/find-a-doctor/daniel-spogen.  “It is an honor to recognize Marie McCormack, MD, and Daniel Spogen, MD, of Renown Health with the Excellence in Healthcare Awards for their deserving work,” said Joe M. Inguanzo, Ph.D., President and CEO of PRC. “It takes true dedication and determination to achieve this level of excellence in healthcare and Renown has shown their commitment to making their hospital and medical practices a better place to work, a better place to practice medicine, and a better place for patients to be treated.” To learn more about healthcare services or to schedule an appointment with a Renown Medical Group or University Health provider, visit mychart.renown.org or call our agents available by phone- Wed-Fri: 7 a.m. to 7 p.m., Sat-Sun: 7 a.m. to 6 p.m., at 775-982-5000. Renown Health is hiring! To join the Renown Health team visit www.renown.org/careers. To learn more about the 2022 Excellence in Healthcare Awards, including eligibility and criteria, visit PRCCustomResearch.com.  About PRC PRC, a leader in the healthcare intelligence space with the most comprehensive healthcare discovery platform, is taking surveys to a new level. PRC’s surveys and intuitive reporting focus on changing the way organizations manage and improve five key areas of the healthcare experience—patient, physician, employee, community, and brand. Over 2,800 healthcare organizations across the United States have used PRC to listen, understand, and take action to create cultures of excellence. To ensure clients have access to leading practices, coaches, and learning resources, PRC is partnered with Healthcare Experience Foundation (HXF) to accelerate paths to excellence. The PRC healthcare discovery platform is a system designed to drive action, optimize engagement, and increase loyalty while building a positive culture across the healthcare ecosystem. www.PRCCustomResearch.com About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team visit www.renown.org/careers.

Leer más About Reno Home to Two of the Nation's Best Physician Communicators

Today, Renown Health announced the appointment of William “Bill” Plauth, MD, MMM, CPE as Chief Medical Officer for Renown Health, effective 3 de abril de 2023. “I am excited to have Dr. Plauth join our team," said Brian Erling, MD, MBA, President & CEO of Renown Health. “Dr. Plauth is a distinguished physician with over 30 years of experience. Dr. Plauth’s extensive commitment to service is in alignment with our mission, vision, and values. He is a goal-oriented, collaborative executive who brings a depth of experience to Renown Health and to our community. He inspires others with his intelligence and proven abilities to engage others in advancing clinical quality and performance. I look forward to the strides our health system will make in helping people live better and healthier lives under his leadership.” In his role as Chief Medical Officer (CMO), Dr. Plauth will be responsible for continuous quality improvement, effective clinical resource management and serve as a liaison for organized medical staff activities. He will partner with nursing leadership to actively support performance improvement, risk management, and efficient resource utilization linked to evidence-based medicine. He will listen and foster a close relationship between and among physicians, management, and clinical staff. As CMO, Dr. Plauth will provide expertise, coordination, and leadership in support of elected medical staff leaders and partner with UNR Med leadership to ensure a positive training environment across Renown Health. “As a physician, I have always been humbled by the trust our patients and their families invest in all of us as a healthcare team,” says Bill Plauth, MD. “Over the years, to fulfill that trust, I have enjoyed engaging with my colleagues across clinical teams to adopt innovative approaches that respect those who do the work and to promote ease of practice. Such collaboration makes it possible for us to provide top-notch, compassionate care that addresses our patients' unique challenges and to improve their health and quality of life. At the end of the day, it is the people that make the difference.” Dr. Plauth adds, “I am delighted to join Renown Health, which as a not-for-profit, charitable health care organization has a long history of compassionate service. I look forward to working with my new medical, nursing, and administrative colleagues as we fulfill our mission of making a genuine difference in the health and wellbeing of the people and communities we serve.” Renown Health has more than 7,200 employees and serves Northern Nevada, Lake Tahoe, and Northeast California. The system includes Renown Regional Medical Center, Renown South Meadows Medical Center, Renown Rehabilitation Hospital and Renown Children’s Hospital. Renown also has over 50 medical group, urgent care, and outpatient imaging practices. Hometown Health is the insurance division of Renown Health and is northern Nevada’s largest local, not-for- profit health insurance company that provides wide-ranging medical coverage. Since 2014, Dr. Plauth has provided clinical leadership at Centura Health (CO), first serving as Chief Medical Officer at Mercy Regional Medical Center in Durango, CO, and then for the last four years as Chief Medical Officer for Centura Penrose & St. Francis Hospitals in Colorado Springs. He was responsible for clinical quality, high reliability patient safety initiatives, process improvement, pharmacy, care management, infection control and medical staff services. Formerly, Dr. Plauth served for fourteen years with CHRISTUS St. Vincent Regional Medical Center in Santa Fe, NM, first as a hospitalist and then with concurrent roles that included Chief of Staff; Medical Director, Clinical Informatics; Medical Director, Palliative Care and Acting Chief Medical Officer for Quality and Medical Staff Affairs. Board certified in both Internal Medicine and Hospice & Palliative Care, Dr. Plauth is a leader in quality improvement, patient safety and clinical informatics. He has also served as a medical director of a Long-Term Care and Skilled Nursing Center. Dr. Plauth received his Bachelor of Arts in Economics from the University of Virginia, Charlottesville, and his Medical Doctorate from Emory University in Atlanta with a sub-internship at Brigham and Women’s Hospital in Boston. He completed his internship and residency at University of California San Francisco, where he also served as Chief Resident. In the most recent U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada. Ningún otro hospital en Nevada obtuvo el reconocimiento de U.S. News. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit www.renown.org/careers.

Leer más About William 'Bill' Plauth, MD, MMM, CPE Appointed Chief Medical Officer for Renown Health